There are rules about when trading updates are required. Mostly they are needed if performance is materially better or worse than the market's expectation.Don't think unscheduled updates are encouraged unless there is a valid reason. |
Their Financial Calendar states half year end on 31 January with results out early April. I'd like to think a trading update could be issued in February to give us a steer on how things are progressing. |
One of those rivals considered slower to adapt is presumably THG, who are almost twice as big but shrinking. (And whose products only part overlap)
Meanwhile a little mention in yesterday's papers:
Ad campaign on ITV runs till mid-March. |
Has been added to Baillie Gifford's managed fund on the grounds of entrepreneurial managers, esp CEO, quicker than competitors to adapt to the market, ability to sell into 80 countries, and making some progress in retail and in USA where it's been adopted by Walmart for space on their shelves. Also it's high margin cash generative.
Can adapt quicker than competitors as it's vertically integrated to a great extent. |
Anyone know of any forthcoming trading update? |
"As of 2023, according to the International Padel Federation (FIP) there are more than 25 million active players in more than 90 countries. Padel is worth about €2bn a year and growing fast." "Three padel courts can fit in one tennis court so many tennis clubs are converting tennis courts to padel courts as it is more profitable for business owners." " Padel is competing with tennis and squash, whose popularity is declining." |
Big free plug for APN products in The Sun: |
Get ready: |
23 days ago the product I wanted was out of stock. I have not had an email saying available and is still listed as out of stock. Good news to bad news??? |
Coleen Rooney, I'm told, has already mentioned her use of collagen supplements, on the current 'I'm-A-Celebrity ..' tv show - though obviously not the brand name in that context. |
Stockmarket rival THG is in longrunning decline but has paused today.
THG now £525m cap vs APN at £325m cap. |
A slightly laddish "Hey look at us, up here on the stockmarket" article from local rag 3 days ago:
Nothing new in it. Except I didn't realise the brand name existed before Ryder came along.
Meanwhile brand ambassador Coleen Rooney flies to Australia today for the filming of I'm-A-Celeb. A programme I don't watch but will bump up her ratings I guess when it goes out. Especially if she wins it. (Goes live Nov 17 to Dec 8). Her tv ad campaign for Applied Nutrition follows in January. |
.
Floated 140p, Nos 250m, Mcap 350m, Date: 24 Oct 2024
As of 31 July 24 - Net cash 18.7m, Net profit 18.6m, eps 7.4p, NAV 48m
Float p/e ratio = 18.8
1 month
Prospectus
Major shareholders on admission
Thomas Ryder (founder & Ceo) 30%
Steven Granite COO 5%
JD Sports 5% |
elbrus55 - thank you. I have amended post No.38 accordingly. |
I don't think APN is currently a consituent of any FTSE UK Index series.Based on current details, it would be expected to be added to the FTSE Small Cap (and All-Share) with effect from opening on 23 December 2024, with a decision about this announced after close on 4 December. |
Someone on another BB asked where the company ranks in size, and in what index.
Current share price at 140.75p places APN's market capitalisation around 393rd in FTSE rankings. I think.
So call it "top 400" (just).
Somewhere around 182p (say 30% up) would place it within reach of the FTSE-250
Somewhere around 222p (say 58% up) would see it automatically enter the FTSE-250.
Meanwhile it is within the FTSE-Smallcap index. (or is likely to be when the next index review occurs confirming status - see Post 39)
(part of the Main Market, not AIM) (AIM runs alongside main market, not beneath). |
Website headline says heavy demand causing delivery delays. Added |
Wrong thread - GOOD |
 Indicative bid must be at or near 500p for the BoD to announce that they are even considering it. Otherwise they would have just sat on the approach as so many other companies do and then announced that they had rejected it as undervaluing the company's prospects.It's possible that Esyasoft could have been badly advised to submit an offer that had no likely prospect of being accepted by the BoD. Given that Dale was willing to pay 400p himself, it seems unlikely that he would accept anything under 500p (and probably more) to sell unless he wanted to move on.
Hence, this has the feel of two possibilities a) a badly advised non-credible approach certain to be rejected by both the BoD and Vincent at something under 400p or b) a knock-out bid at something considerably higher than 500p which has been pre-approved by Dale and which the BoD feel obliged to consider properly. Given that Esyasoft are a credible player looking to enter the UK market with buckets of cash behind them, it would seem that b) is the more likely option. Obviously, if it turns out to be a) then the price is likely too drop back to around 300p. But given the upside is 500p or better, the risk/reward looks quite good here for a share that has plenty of potential to grow anyway.
Hence, I am adding at the current level and will continue to hold in the absence of a credible bid.
There is always the possibility that a less than credible bid is backed up with a threat from Esyasoft that they will enter the market anyway and compete using their buckets of cash. But I don't see that as a particularly credible threat. |
"So far Applied Nutrition has racked up an impressive record: revenues have grown by around 4 times since 2021, and analysts at the broker Panmure Liberum think that sales could hit £100 million by the end of its next financial year." (The Times, today)
(I can't access the whole article at present. Paywall) |
Chart looks remarkably orderly in its neat little approach to its end-of-week 135p. Like it's been carefully parked there. |
120p once the shorts take it down..? |
The shares have taken a dump ! |
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
